These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 8650186)

  • 1. The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice.
    Böttinger EP; Factor VM; Tsang ML; Weatherbee JA; Kopp JB; Qian SW; Wakefield LM; Roberts AB; Thorgeirsson SS; Sporn MB
    Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5877-82. PubMed ID: 8650186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of carbohydrate structures in the binding of beta1-latency-associated peptide to ligands.
    Yang Y; Dignam JD; Gentry LE
    Biochemistry; 1997 Sep; 36(39):11923-32. PubMed ID: 9305986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor beta-1 and beta-2 in human tear fluid.
    Gupta A; Monroy D; Ji Z; Yoshino K; Huang A; Pflugfelder SC
    Curr Eye Res; 1996 Jun; 15(6):605-14. PubMed ID: 8670763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latent transforming growth factor-beta complex in Chinese hamster ovary cells contains the multifunctional cysteine-rich fibroblast growth factor receptor, also termed E-selectin-ligand or MG-160.
    Olofsson A; Hellman U; Ten Dijke P; Grimsby S; Ichijo H; Morén A; Miyazono K; Heldin CH
    Biochem J; 1997 Jun; 324 ( Pt 2)(Pt 2):427-34. PubMed ID: 9182700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P311 binds to the latency associated protein and downregulates the expression of TGF-beta1 and TGF-beta2.
    Paliwal S; Shi J; Dhru U; Zhou Y; Schuger L
    Biochem Biophys Res Commun; 2004 Mar; 315(4):1104-9. PubMed ID: 14985127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta.
    Ribeiro SM; Poczatek M; Schultz-Cherry S; Villain M; Murphy-Ullrich JE
    J Biol Chem; 1999 May; 274(19):13586-93. PubMed ID: 10224129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta-1 latency-associated peptide and soluble betaglycan prevent a glucose-induced increase in fibronectin production in cultured human mesangial cells.
    Nomura K; Tada H; Kuboki K; Inokuchi T
    Nephron; 2002 Aug; 91(4):606-11. PubMed ID: 12138262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural characterization of the latent complex between transforming growth factor beta 1 and beta 1-latency-associated peptide.
    McMahon GA; Dignam JD; Gentry LE
    Biochem J; 1996 Jan; 313 ( Pt 1)(Pt 1):343-51. PubMed ID: 8546705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of transforming growth factor beta1 by nitric oxide.
    Vodovotz Y; Chesler L; Chong H; Kim SJ; Simpson JT; DeGraff W; Cox GW; Roberts AB; Wink DA; Barcellos-Hoff MH
    Cancer Res; 1999 May; 59(9):2142-9. PubMed ID: 10232601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant truncated latency-associated peptide alleviates liver fibrosis in vitro and in vivo via inhibition of TGF-β/Smad pathway.
    Song X; Shi J; Liu J; Liu Y; Yu Y; Qiu Y; Cao Z; Pan Y; Yuan X; Chu Y; Wu D
    Mol Med; 2022 Jul; 28(1):80. PubMed ID: 35842576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between growth factors and integrins: latent forms of transforming growth factor-beta are ligands for the integrin alphavbeta1.
    Munger JS; Harpel JG; Giancotti FG; Rifkin DB
    Mol Biol Cell; 1998 Sep; 9(9):2627-38. PubMed ID: 9725916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Domain-specific mutations of a transforming growth factor (TGF)-beta 1 latency-associated peptide cause Camurati-Engelmann disease because of the formation of a constitutively active form of TGF-beta 1.
    Saito T; Kinoshita A; Yoshiura Ki ; Makita Y; Wakui K; Honke K; Niikawa N; Taniguchi N
    J Biol Chem; 2001 Apr; 276(15):11469-72. PubMed ID: 11278244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmented binding and activation of latent transforming growth factor-beta by a tryptic fragment of latency associated peptide.
    Abe M; Oda N; Sato Y; Shibata K; Yamasaki M
    Endothelium; 2002; 9(1):25-36. PubMed ID: 12901358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta.
    Hirsch CS; Ellner JJ; Blinkhorn R; Toossi Z
    Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3926-31. PubMed ID: 9108081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular interactions that confer latency to transforming growth factor-beta.
    Young GD; Murphy-Ullrich JE
    J Biol Chem; 2004 Sep; 279(36):38032-9. PubMed ID: 15208302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latent transforming growth factor beta1 activation in situ: quantitative and functional evidence after low-dose gamma-irradiation.
    Ehrhart EJ; Segarini P; Tsang ML; Carroll AG; Barcellos-Hoff MH
    FASEB J; 1997 Oct; 11(12):991-1002. PubMed ID: 9337152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and secretion of transforming growth factor beta (TGF-beta) by the human lacrimal gland.
    Yoshino K; Garg R; Monroy D; Ji Z; Pflugfelder SC
    Curr Eye Res; 1996 Jun; 15(6):615-24. PubMed ID: 8670764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential changes in transforming growth factor-beta isoform expression during postnatal cardiac growth.
    Haworth RS; Brooks G; Cummins P; Dobie K; Chilton DC; Avkiran M
    Biochem Biophys Res Commun; 1998 Apr; 245(3):923-7. PubMed ID: 9588216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoform-specific activation of latent transforming growth factor beta (LTGF-beta) by reactive oxygen species.
    Jobling MF; Mott JD; Finnegan MT; Jurukovski V; Erickson AC; Walian PJ; Taylor SE; Ledbetter S; Lawrence CM; Rifkin DB; Barcellos-Hoff MH
    Radiat Res; 2006 Dec; 166(6):839-48. PubMed ID: 17149983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of transforming growth factor-beta1 and type II receptor in developing normal human prostate and carcinoma tissues.
    Gerdes MJ; Larsen M; McBride L; Dang TD; Lu B; Rowley DR
    J Histochem Cytochem; 1998 Mar; 46(3):379-88. PubMed ID: 9487120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.